118 related articles for article (PubMed ID: 15336529)
1. Expression of metalloproteinases and inhibitors in the differentiation of P19CL6 cells into cardiac myocytes.
Young DA; Gavrilov S; Pennington CJ; Nuttall RK; Edwards DR; Kitsis RN; Clark IM
Biochem Biophys Res Commun; 2004 Sep; 322(3):759-65. PubMed ID: 15336529
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of cardiomyocytes differentiation in mouse embryonic carcinoma P19CL6 cells.
Wen J; Xia Q; Lu C; Yin L; Hu J; Gong Y; Yin B; Monzen K; Yuan J; Qiang B; Zhang X; Peng X
J Cell Biochem; 2007 Sep; 102(1):149-60. PubMed ID: 17520663
[TBL] [Abstract][Full Text] [Related]
3. Microarray analysis of global changes in gene expression during cardiac myocyte differentiation.
Peng CF; Wei Y; Levsky JM; McDonald TV; Childs G; Kitsis RN
Physiol Genomics; 2002; 9(3):145-55. PubMed ID: 12045295
[TBL] [Abstract][Full Text] [Related]
4. Cardiac differentiation of P19CL6 cells by oxytocin.
Fathi F; Murasawa S; Hasegawa S; Asahara T; Kermani AJ; Mowla SJ
Int J Cardiol; 2009 May; 134(1):75-81. PubMed ID: 18538425
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of P19CL6 with multiple reagents induces pulsating particles in vivo.
Ohtsu Y; Johkura K; Ito K; Akashima T; Asanuma K; Ogiwara N; Oka T; Komuro I; Sasaki K; Amano J
Curr Med Res Opin; 2005 May; 21(5):795-803. PubMed ID: 15969879
[TBL] [Abstract][Full Text] [Related]
6. Activation of the gene for atrial natriuretic factor during in vitro cardiac myogenesis by P19 embryonal carcinoma cells.
Boer PH
Exp Cell Res; 1993 Aug; 207(2):421-9. PubMed ID: 8344390
[TBL] [Abstract][Full Text] [Related]
7. 8-Methyltryptanthrin-induced differentiation of P19CL6 embryonal carcinoma cells into spontaneously beating cardiomyocyte-like cells.
Seya K; Yamaya A; Kamachi S; Murakami M; Kitahara H; Kawakami J; Okumura K; Murakami M; Motomura S; Furukawa K
J Nat Prod; 2014 Jun; 77(6):1413-9. PubMed ID: 24885014
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of nucleosome assembly protein 1-like 1 promotes dimethyl sulfoxide-induced differentiation of P19CL6 cells into cardiomyocytes.
Li L; Gong H; Yu H; Liu X; Liu Q; Yan G; Zhang Y; Lu H; Zou Y; Yang P
J Cell Biochem; 2012 Dec; 113(12):3788-96. PubMed ID: 22807403
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide signaling in oxytocin-mediated cardiomyogenesis.
Danalache BA; Paquin J; Donghao W; Grygorczyk R; Moore JC; Mummery CL; Gutkowska J; Jankowski M
Stem Cells; 2007 Mar; 25(3):679-88. PubMed ID: 17138963
[TBL] [Abstract][Full Text] [Related]
10. P19 progenitor cells progress to organized contracting myocytes after chemical and electrical stimulation: implications for vascular tissue engineering.
Abilez O; Benharash P; Miyamoto E; Gale A; Xu C; Zarins CK
J Endovasc Ther; 2006 Jun; 13(3):377-88. PubMed ID: 16784327
[TBL] [Abstract][Full Text] [Related]
11. 3,5,3'-Triiodo-L-thyronine induces cardiac myocyte differentiation but not neuronal differentiation in P19 teratocarcinoma cells in a dose dependent manner.
Rodriguez ER; Tan CD; Onwuta US; Yu ZX; Ferrans VJ; Parrillo JE
Biochem Biophys Res Commun; 1994 Nov; 205(1):652-8. PubMed ID: 7999094
[TBL] [Abstract][Full Text] [Related]
12. P19 embryonal carcinoma cells.
McBurney MW
Int J Dev Biol; 1993 Mar; 37(1):135-40. PubMed ID: 8507558
[TBL] [Abstract][Full Text] [Related]
13. Influence of persistent canine distemper virus infection on expression of RECK, matrix-metalloproteinases and their inhibitors in a canine macrophage/monocytic tumour cell line (DH82).
Puff C; Krudewig C; Imbschweiler I; Baumgärtner W; Alldinger S
Vet J; 2009 Oct; 182(1):100-7. PubMed ID: 18684651
[TBL] [Abstract][Full Text] [Related]
14. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts.
Cury PR; de Araújo VC; Canavez F; Furuse C; Leite KR; de Araújo NS
Arch Oral Biol; 2007 Jun; 52(6):585-90. PubMed ID: 17181997
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
16. Intracellular localization of matrix metalloproteinases and their inhibitors in cultured tumor cell lines: flow cytometric analysis.
Koyama S
Oncol Rep; 2006 Mar; 15(3):735-8. PubMed ID: 16465438
[TBL] [Abstract][Full Text] [Related]
17. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
[TBL] [Abstract][Full Text] [Related]
18. A P19 and P19CL6 cell-based complementary approach to determine paracrine effects in cardiac tissue engineering.
Dehne T; Adam X; Materne EM; Reimann MC; Krüger JP; Van Linthout S; Tschöpe C; Haag M; Sittinger M; Ringe J
Cells Tissues Organs; 2014; 199(1):24-36. PubMed ID: 25170977
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms.
Schmoker JD; McPartland KJ; Fellinger EK; Boyum J; Trombley L; Ittleman FP; Terrien C; Stanley A; Howard A
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):155-61. PubMed ID: 17198804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
